子痫前期动物模型:病理生理机制与治疗靶点研究
本文综述了用于研究子痫前期病理生理机制的主要动物模型,包括胎盘缺血、血管生成失衡和母体免疫激活模型,以及因子输注、肾素-血管紧张素系统过表达、补体激活和滋养细胞分化等遗传模型。研究多在大鼠和小鼠中进行,也纳入了非人灵长类模型;这些模型有助于理解子痫前期病理生理并寻找新的治疗选择。
要点
- 胎盘缺血、血管生成失衡和母体免疫激活是子痫前期研究中最常用的动物模型类型。
- 向动物输注子痫前期相关因子有助于明确该病特定介质的致病作用。
- 动物模型是研究子痫前期病理生理和探索新治疗选择的重要工具。
核心结论
- 动物模型在子痫前期病理生理研究和治疗靶点探索中具有重要价值,并持续作为寻找新治疗选择的重要工具。
研究设计与样本
- 本文为简要综述,汇总了子痫前期研究中较广泛使用的动物模型;多数动物研究在大鼠和小鼠中进行,并纳入了非人灵长类模型。
主要发现
- 综述涵盖胎盘缺血、血管生成失衡和母体免疫激活模型,以及子痫前期相关因子输注模型。
- 遗传模型涉及肾素-血管紧张素系统过表达、补体激活和滋养细胞分化。
- 这些模型覆盖从滋养细胞功能障碍、胎盘血管化受损到循环胎盘因子过多及临床表型的多种机制。
临床怎么用
- 临床前动物模型可用于概念验证研究,检验子痫前期患者中发现的某些因子是否介导高血压及其他表现。
- 动物模型有助于在无法对患者进行详细定量研究时探索时间依赖性机制。
- 这些模型可支持子痫前期新治疗选择的临床前评估。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Animal models have been critical in investigating the pathogenesis, mediators, and even therapeutic options for a number of diseases, including preeclampsia. Preeclampsia is the leading cause of maternal and fetal morbidity and mortality worldwide. The placenta is thought to play a central role in the pathogenesis of this disease because it releases antiangiogenic and proinflammatory factors into the maternal circulation, resulting in the maternal syndrome. Despite the deleterious effects preeclampsia has been shown to have on the mother and baby during pregnancy and postpartum, there is still no effective treatment for this disease. Although clinical studies in patients are crucial to identify the involvement of pathogenic factors in preeclampsia, there are obvious limitations that prevent detailed investigation of the quantitative importance of time-dependent mechanisms involved in this syndrome. Animal models allow investigators to perform proof-of-concept studies and examine whether certain factors found in women with preeclampsia mediate hypertension and other manifestations of this disease. In this brief review, we summarize some of the more widely studied models used to investigate pathophysiological mechanisms that are thought to be involved in preeclampsia. These include models of placental ischemia, angiogenic imbalance, and maternal immune activation. Infusion of preeclampsia-related factors into animals has been widely studied to understand the specific mediators of this disease. These models have been included, in addition to a number of genetic models involved in overexpression of the renin-angiotensin system, complement activation, and trophoblast differentiation. Together, these models cover multiple mechanisms of preeclampsia from trophoblast dysfunction and impaired placental vascularization to the excess circulating placental factors and clinical manifestation of this disease. Most animal studies have been performed in rats and mice; however, we have also incorporated nonhuman primate models in this review. Preclinical animal models not only have been instrumental in understanding the pathophysiology of preeclampsia but also continue to be important tools in the search for novel therapeutic options for the treatment of this disease.
引用
- Bakrania BA, George EM, Granger JP, et al. Animal models of preeclampsia: investigating pathophysiology and therapeutic targets. Am J Obstet Gynecol. 2021. PMID: 33722383. doi:10.1016/j.ajog.2020.10.025
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。